This Article Full Text Full Text (PDF) Supplementary Data Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Felix, K. Articles by Janz, S. Search for Related Content PubMed PubMed Citation Articles by Felix, K. Articles by Janz, S.

Selenium Deficiency Abrogates Inflammation-Dependent Plasma Cell Tumors in Mice

¹ Laboratory of Genetics, Center for Cancer Research, National Cancer Institute and ² Veterinary Resources Program, NIH, Bethesda, Maryland; ³ Institute of Clinical Molecular Biology and Tumor Genetics, GSF, Munich, Germany; ⁴ Hahn Meitner Institute, Berlin, Germany; and ⁵ Laboratory of Immunoregulation, National Cancer Institute and ⁶ Science Applications International Corp., Frederick, Maryland

The role of the micronutrient, selenium, in human cancers associated with chronic inflammations and persistent infections is poorly understood. Peritoneal plasmacytomas (PCTs) in strain BALB/c (C), the premier experimental model of inflammation-dependent plasma cell transformation in mice, may afford an opportunity to gain additional insights into the significance of selenium in neoplastic development. Here, we report that selenium-depleted C mice (n = 32) maintained on a torula-based low-selenium diet (5–8 µg of selenium/kg) were totally refractory to pristane induction of PCT. In contrast, 11 of 26 (42.3%) control mice maintained on a selenium adequate torula diet (300 µg of selenium/kg) and 15 of 40 (37.5%) control mice fed standard Purina chow (440 µg of selenium/kg) developed PCT by 275 days postpristane. Abrogation of PCT was caused in part by the striking inhibition of the formation of the inflammatory tissue in which PCT develop (pristane granuloma). This was associated with the reduced responsiveness of selenium-deficient inflammatory cells (monocytes and neutrophils) to chemoattractants, such as thioredoxin and chemokines. Selenium-deficient C mice exhibited little evidence of disturbed redox homeostasis and increased mutant frequency of a transgenic lacZ reporter gene in vivo. These findings implicate selenium, via the selenoproteins, in the promotion of inflammation-induced PCT and suggest that small drug inhibitors of selenoproteins might be useful for preventing human cancers linked with chronic inflammations and persistent infections.

This article has been cited by other articles:

				P. A. Sheridan, N. Zhong, B. A. Carlson, C. M. Perella, D. L. Hatfield, and M. A. Beck Decreased Selenoprotein Expression Alters the Immune Response during Influenza Virus Infection in Mice J. Nutr., June 1, 2007; 137(6): 1466 - 1471. [Abstract] [Full Text] [PDF]